Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 23797758)

1.

Coronary Artery Disease in the Human Immunodeficiency Virus Seropositive Population.

Barakat MG, Arora RR.

Am J Ther. 2013 Jun 21. [Epub ahead of print]

PMID:
23797758
2.

[Atherosclerosis in HIV-positive patients].

Neumann T, Miller M, Esser S, Gerken G, Erbel R.

Z Kardiol. 2002 Nov;91(11):879-88. Review. German.

PMID:
12442190
3.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
4.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
5.

HIV infection, highly active antiretroviral therapy and the cardiovascular system.

Barbaro G.

Cardiovasc Res. 2003 Oct 15;60(1):87-95. Review.

6.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
7.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
8.
9.

Rapid progression of atherosclerotic coronary artery disease in patients with human immunodeficiency virus infection.

Spieker LE, Karadag B, Binggeli C, Corti R.

Heart Vessels. 2005 Jul;20(4):171-4.

PMID:
16025368
10.

Cardiovascular disease in HIV infection.

Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF.

Am Heart J. 2006 Jun;151(6):1147-55. Review.

PMID:
16781213
11.

[Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].

Miró JM, Manzardo C, Zamora L, Pumarola T, Herreras Z, Gallart T, Gatell JM.

Enferm Infecc Microbiol Clin. 2011 Dec;29(10):759-72. doi: 10.1016/j.eimc.2011.10.009. Epub 2011 Nov 10. Review. Spanish.

PMID:
22078726
14.

Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy.

Talwani R, Falusi OM, Mendes de Leon CF, Nerad JL, Rich S, Proia LA, Sha BE, Smith KY, Kessler HA.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):191-5.

PMID:
12045682
15.
16.

Human immunodeficiency virus infection: personal experience in changes in head and neck manifestations due to recent antiretroviral therapies.

Campanini A, Marani M, Mastroianni A, Cancellieri C, Vicini C.

Acta Otorhinolaryngol Ital. 2005 Feb;25(1):30-5.

17.

Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease.

Kimmel PL, VedBrat SS, Pierce PF, Umana WO, Shepherd L, Verme DA, Hirsch RP, Hellman KB.

Arch Intern Med. 1995 Aug 7-21;155(15):1578-84.

PMID:
7618979
18.

Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.

Fung HB, Kirschenbaum HL, Hameed R.

Clin Ther. 2000 May;22(5):549-72. Review.

PMID:
10868554
19.

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Gaughan DM, Mofenson LM, Hughes MD, Seage GR 3rd, Ciupak GL, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

Pediatrics. 2002 May;109(5):E74-4.

PMID:
11986480
20.

[Acute coronary syndromes in patients treated with HIV protease inhibitors].

Barthélémy O, Escaut L, Vayre F, Gallet B, Pulik M, Heloire F, Vittecoq D.

Presse Med. 2002 Mar 2;31(8):343-8. French.

PMID:
11913076
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk